Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.26852Source: DataRank Database

Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults is a research paper published in JAMA Network Open (2023). On theSindex it has a DataRank of 0. It has been cited 31 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access31 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: goldTopics (65)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Kaleen N. Hayes ORCID,Andrew R. Zullo ORCID,Vincent Mor ORCID,Preeti Chachlani,Yalin Deng

Live enrichment

PubMed:37531110 PMC:PMC10398407

National Institutes of Health

Grant: 3U54AG063546-02S6

NIA AD/ADRD Health Care Systems Research Collaboratory

goldLicense: cc-by

publisherhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2807927/harris_2023_oi_230773_1690380890.26098.pdf

repositoryhttps://www.mountsinai.org/files/MSHealth/Assets/HS/About/Coronavirus/MSHS_COVID-19-Vaccine-Ingredients-Pfizer-Moderna-Chart.pdf

Europe_PMChttps://europepmc.org/articles/PMC10398407

https://doi.org/10.1001/jamanetworkopen.2023.26852

https://pubmed.ncbi.nlm.nih.gov/37531110

Fields of Study

03 medical and health sciences0302 clinical medicineUnited StatesHumansAgedFemaleAdultMiddle AgedMaleCOVID-19 Vaccines2019-nCoV Vaccine mRNA-1273BNT162 VaccineCohort StudiesFrailtyRetrospective StudiesCOVID-19MedicareSARS-CoV-2VaccinationmRNA VaccinesThrombocytopeniaPurpuraRNA, Messenger

MeSH Terms

HumansPurpuraThrombocytopeniaRNA, MessengerVaccinationRetrospective StudiesCohort StudiesAdultAgedMiddle AgedMedicareUnited StatesFemaleMaleFrailtyCOVID-19SARS-CoV-2COVID-19 VaccinesmRNA VaccinesBNT162 Vaccine2019-nCoV Vaccine mRNA-1273

Keywords

AdultMaleCOVID-19 VaccinesFrailtySARS-CoV-2VaccinationCOVID-19Middle AgedMedicareThrombocytopeniaUnited StatesCohort StudiesHumansFemalemRNA VaccinesBNT162 VaccinePurpuraOriginal InvestigationAged2019-nCoV Vaccine mRNA-1273Retrospective Studies

Sustainable Development Goals

SDG 3: 3. Good health